Work

C-A4-05: Design for Identification, Retrieval and Adjudication of Acute Myocardial Infarction Cases in the Mini-Sentinel Distributed Database

Year: 2011

Type: article

Abstract: HMORN -Selected Abstracts > 85%, while the completion rate for anticonvulsants ranged from 30-75%.The lowest test completion rate was for phenobarbital levels to monitor phenobarbital (30%).For all cardiovascular and anticonvulsant drugs, the proportion of recommended tests not ordered by the clinician ranged from 5% to 60%.The lowest test order prevalence was for phenobarbital level for phenobarbital use (35%), followed by valproic acid level for valproate use(48%), and carbamazepine level for carbamazepine use (60%).Rates of patient noncompletion of ordered tests for all drugs was generally <10%.Conclusion: Completion of laboratory monitoring tests for high-risk cardiovascular medications was higher than for high-risk anticonvulsants according to HEDIS guidelines.Clinician ordering behavior exhibited more variation than patient adherence to test orders.Underestimation of HEDIS quality of care monitoring due to patient non-adherence is minimal for cardiovascular medications, but higher for anticonvulsants.

Source: Clinical Medicine & Research

DOI: 10.3121/cmr.2011.1020.c-a4-05

Authors: S. Cutrona, S. Foy, D. Toh, A. Iyer, S. Forrow, J. Gurwitz

Institutions: University of Massachusetts Chan Medical School, Harvard Pilgrim Health Care

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2023824926